FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

41448211000001105: Zejula 100mg tablets (GlaxoSmithKline UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Apr 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2912001000001111 Zejula 100mg tablets (GlaxoSmithKline UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2912021000001116 Zejula 100mg tablets (GlaxoSmithKline UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Is a Niraparib 100mg tablets true Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Is a Zejula true Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Has specific active ingredient Niraparib tosylate monohydrate true Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Niraparib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 12 x 7 tablets Has AMP True Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier
Zejula 100mg tablets (GlaxoSmithKline UK Ltd) 56 tablet 8 x 7 tablets Has AMP True Zejula 100mg tablets (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start